anonymous
Guest
anonymous
Guest
Tad and Novartis, should you think that absconding with 3.5% to 4.5% from the eye care representatives has gone unnoticed, your presumption is mistaken. We saw this dirty deed coming that diminished earnings and plummeting rankings for individuals as a result of your deliberate actions. It is perplexing to rationalize how you reconcile your actions with a conscience, having breached the trust of your team so more could be added to the bottom line. My time in the field for the year ended yesterday. I will go into the holidays with an absence of communication on how this will be rectified. To all those affected, encompassing the entire field force, I feel for you and I am sorry we were all taken advantage of. This is on Novartis and not Bausch. Merry Christmas.